OFA Group — Form 8-K Summary
Filing date: October 9, 2026. Meeting/event date: October 5, 2026. This Form 8-K reports shareholder votes at the company’s annual meeting; it does not report quarterly or annual financial results.
Business context and key actions
As of the September 17, 2026 record date, OFA Group had 6,453,481 Class A shares outstanding, each with one vote, and 20,000,000 Class B shares outstanding, each with 25 votes. Shareholders approved all nine proposals. The filing does not provide operating or financial performance metrics, cash flow, margins, debt, or liquidity figures.
- Re-elected six directors—Larry Wong, Keith Chong, John Chiang, Andrew Scott, Erwin Baquiran Pineda, and Yan Xu—through the 2027 annual meeting.
- Ratified M&K CPAS, PLLC as independent auditor for the fiscal year ending March 31, 2027.
- Approved the Third Amended and Restated Memorandum and Articles of Association associated with a previously approved 10-for-1 consolidation of Class A shares.
- Approved a 10-for-1 consolidation of authorized but undesignated, unissued shares, an authorized share-capital increase subject to that consolidation, and related amended articles. The Fourth Amended and Restated Memorandum and Articles became effective on October 5, 2026.
- Authorized the Board, through the next annual meeting, to implement one or more additional consolidations of Class A and specified undesignated shares, with a cumulative ratio from 2-for-1 to 25-for-1. The filing does not specify whether or when the Board will use this authority.
- Approved share issuance under the July 14, 2025 equity line purchase agreement with Atsion Opportunity Fund LLC – Series 1. OFA may, but is not required to, sell up to $100 million of Class A shares over the agreement’s 36-month term, subject to its terms and limitations.
Material changes, outlook, and risks
The key capital-structure developments are the approved share consolidations and authorization for a possible increase in authorized share capital. Further consolidations remain at the Board’s discretion. The approved equity line could provide access to capital but may dilute existing shareholders if shares are issued. The filing gives no financial outlook, forecast, or management commentary on operating performance, and does not state that any equity-line shares have been sold.
Most important facts to verify
- Whether the approved share-capital increase and 10-for-1 consolidation of undesignated shares have been completed, and the resulting authorized and outstanding share counts.
- Whether the Board will implement any additional consolidations, and the timing and cumulative ratio if it does.
- Whether OFA has drawn on the Atsion equity line, the shares issued and proceeds received, and the remaining availability and term.
- Current financial statements and liquidity information, which are not included in this 8-K.